Activation of TFEB-mediated lysosomal biogenesis to degrade protein aggregates is beneficial to NDs that are characterized by the accumulation of protein aggregates, including Alzheimer’s disease (AD) [3] and Parkinson’s disease (PD) [13]. This evidence concerns the gene TFEB and Parkinson disease.